Effects of Ledipasvir/Sofosbuvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) in Patients With HIV.
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Tenofovir alafenamide (Primary)
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- 17 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 1 Aug 2017.
- 09 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jul 2017.
- 26 Apr 2017 New trial record